search for: Remdesivir
161 results (0.589 seconds)
group by podcast
Wie oft wurde "Remdesivir" in Episodentexten gefunden?

podcasts

    Wenn Du in Zukunft über neue Folgen zum Suchbegriff Remdesivir informiert werden möchtest, lege einfach einen Alert dafür an.

    search results

       
       
    • This Week in Virology This Week in Virology
       
      Clinical update with Dr. Daniel Griffin
      April 6, 2024 (duration 49m)
      [from description] ...onvalescent plasma, what do when healthcare workers succumb to SARS-CoV-2 infection, if remdesivir or paxlovid can reduce cardiovascular adverse events and the first finding of the two-year ...
      [from content:encoded] ...onvalescent plasma, what do when healthcare workers succumb to SARS-CoV-2 infection, if remdesivir or paxlovid can reduce cardiovascular adverse events and the first finding of the two-year ...
       
      Clinical update with Dr. Daniel Griffin
      March 30, 2024 (duration 44m)
      [from description] ...es to dispel the myth of viral rebound including that after administration of the “oral remdesivir”, revised guidelines SARS-CoV-2 treatment and how to treat respiratory viral infections, wh...
      [from content:encoded] ...es to dispel the myth of viral rebound including that after administration of the “oral remdesivir”, revised guidelines SARS-CoV-2 treatment and how to treat respiratory viral infections, wh...
       
      Clinical update with Dr. Daniel Griffin
      January 27, 2024 (duration 54m)
      [from description] ... tools (ESMED) How to pay for Paxlovid (PAXCESS) Remdesivir for immunocompromised during variant waves (CID) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for imm...
      [from content:encoded] ... tools (ESMED) How to pay for Paxlovid (PAXCESS) Remdesivir for immunocompromised during variant waves (CID) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for imm...
       
      Clinical update with Dr. Daniel Griffin
      November 18, 2023 (duration 46m)
      [from description] ...compromised immune system, evaluation of the safety profile and therapeutic efficacy of Remdesivir in children with SARS-CoV-2 infection, effect of neutralizing monoclonal antibody treatment...
      [from content:encoded] ...compromised immune system, evaluation of the safety profile and therapeutic efficacy of Remdesivir in children with SARS-CoV-2 infection, effect of neutralizing monoclonal antibody treatment...
       
      Clinical update with Dr. Daniel Griffin
      November 4, 2023 (duration 37m)
      [from description] ...s compared with seasonal influenza and RSV infections in adults (CID) Remdesivir is associated with reduced mortality in COVID-19 patients requiring oxygen (OFID) Effectiveness of nirmatrel...
      [from content:encoded] ...s compared with seasonal influenza and RSV infections in adults (CID) Remdesivir is associated with reduced mortality in COVID-19 patients requiring oxygen (OFID) Effectiveness of nirmatrel...
       
       
      Clinical update with Dr. Daniel Griffin
      September 2, 2023 (duration 48m)
      [from description] ...n XBB.1.5-adapted COVID-19 vaccine in the European Union, clinical antiviral efficacy of Remdesivir in COVID-19, optimal duration of systemic corticosteroids in COVID-19 treatment, clinical ...
      [from content:encoded] ...n XBB.1.5-adapted COVID-19 vaccine in the European Union, clinical antiviral efficacy of Remdesivir in COVID-19, optimal duration of systemic corticosteroids in COVID-19 treatment, clinical ...
       
      Clinical update with Dr. Daniel Griffin
      August 5, 2023 (duration 35m)
      [from description] ...the point of care, effectiveness of oral Nirmatrelvir/Ritonavir vs. intravenous three-day Remdesivir in preventing progression to severe COVID-19, NIH launching of several phase 2 long-COVID...
      [from content:encoded] ...the point of care, effectiveness of oral Nirmatrelvir/Ritonavir vs. intravenous three-day Remdesivir in preventing progression to severe COVID-19, NIH launching of several phase 2 long-COVID...
       
      Clinical update with Dr. Daniel Griffin
      July 29, 2023 (duration 32m)
      [from description] ...e variants in SARS-CoV-2 isolates in Ontario, Canada, viral resistance analyses from the Remdesivir phase 3 adaptive COVID-19 treatment trial-1, impact of Molnupiravir treatment on patient-r...
      [from content:encoded] ...e variants in SARS-CoV-2 isolates in Ontario, Canada, viral resistance analyses from the Remdesivir phase 3 adaptive COVID-19 treatment trial-1, impact of Molnupiravir treatment on patient-r...
       
      Clinical update with Dr. Daniel Griffin
      May 6, 2023 (duration 52m)
      [from description] ...f intubation and ICU mortality in COVID-19 patients, real-life experience with Remdesivir for treatment of COVID-19 among older adults, and how long COVID brain fog and muscle pain are assoc...
      [from content:encoded] ...f intubation and ICU mortality in COVID-19 patients, real-life experience with Remdesivir for treatment of COVID-19 among older adults, and how long COVID brain fog and muscle pain are assoc...
       
      COVID-19 drives autoimmunity
      March 19, 2023 (duration 1h48m)
      [from description] TWiV reveals how treatment with remdesivir for COVID-19 resolved a chronic poliovirus infection in an immunocompromised patient, and...
      [from content:encoded] TWiV reveals how treatment with remdesivir for COVID-19 resolved a chronic poliovirus infection in an immunocompromised patient, and...
      [from itunes:keywords] ...nodeficiency,virology,poliovirus,coronavirus,autoimmunity,autoantibodies,covid19,sarscov2,remdesivir,mrnavaccine,cvdpv,icvdpv
       
      Clinical update with Dr. Daniel Griffin
      March 18, 2023 (duration 31m)
      [from description] ...ongstanding, immune-deficiency-associated, vaccine-derived poliovirus infection following remdesivir therapy for chronic SARS-CoV-2 infection, SARS-CoV-2 exposure in New York City rats, clin...
      [from content:encoded] ...ongstanding, immune-deficiency-associated, vaccine-derived poliovirus infection following remdesivir therapy for chronic SARS-CoV-2 infection, SARS-CoV-2 exposure in New York City rats, clin...
      [from itunes:subtitle] ...ongstanding, immune-deficiency-associated, vaccine-derived poliovirus infection following remdesivir therapy for chronic SARS-CoV-2 infection, SARS-CoV-2 exposure in New York City...
       
      Clinical update with Dr. Daniel Griffin
      November 19, 2022 (duration 46m)
      [from description] ... (Annals of Internal Medicine) Remdesivir fact sheet for providers (Veklury)  Twice daily oral zinc in the treatment of patients with COVID-19 (CID)  Cognitive deficits in long COVID-19 (N...
      [from content:encoded] ... (Annals of Internal Medicine) Remdesivir fact sheet for providers (Veklury)  Twice daily oral zinc in the treatment of patients with COVID-19 (CID)  Cognitive deficits in long COVID-19 (N...
       
      Clinical update with Dr. Daniel Griffin
      November 5, 2022 (duration 49m)
      [from description] ...ong-term gastrointestinal sequelae following COVID-19 (CGH) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Evaluation of an automated text messag...
      [from content:encoded] ...ong-term gastrointestinal sequelae following COVID-19 (CGH) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Evaluation of an automated text messag...
       
      Clinical update with Dr. Daniel Griffin
      October 29, 2022 (duration 45m)
      [from description] ... (CDC) Distinguishing SARS-CoV-2 persistence and reinfection (CID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Novavax triggers potent neutral...
      [from content:encoded] ... (CDC) Distinguishing SARS-CoV-2 persistence and reinfection (CID) Remdesivir fact sheet for providers (Veklury) Bebtelovimab fact sheet for providers (FDA) Novavax triggers potent neutral...
       
      Clinical update with Dr. Daniel Griffin
      October 22, 2022 (duration 33m)
      [from description] ... (The LANCET) Successful immunomodulators for treatment of COVID-19 (CMI) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) PAXLOVID patient eligib...
      [from content:encoded] ... (The LANCET) Successful immunomodulators for treatment of COVID-19 (CMI) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) PAXLOVID patient eligib...
       
      Clinical update with Dr. Daniel Griffin
      October 15, 2022 (duration 44m)
      [from description] ...sease rebound following PAXLOVID (CID) Outpatient treatment with Remdesivir in patients at high risk (OFID) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for provid...
      [from content:encoded] ...sease rebound following PAXLOVID (CID) Outpatient treatment with Remdesivir in patients at high risk (OFID) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for provid...
       
      Clinical update with Dr. Daniel Griffin
      October 8, 2022 (duration 42m)
      [from description] ...ces COVID19 hospitalizations & deaths (EPIC) Paxlovid rebound in COVID19 (NEJM) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Dr. Griffin’s tre...
      [from content:encoded] ...ces COVID19 hospitalizations & deaths (EPIC) Paxlovid rebound in COVID19 (NEJM) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Dr. Griffin’s tre...
       
      Clinical update with Dr. Daniel Griffin
      October 1, 2022 (duration 50m)
      [from description] ...ion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants, short-course early outpatient Remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the Omicron BA.2 ...
      [from content:encoded] ...ion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants, short-course early outpatient Remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the Omicron BA.2 ...
       
      Clinical update with Dr. Daniel Griffin
      September 24, 2022 (duration 53m)
      [from description] ...subgenomic mRNA detection (J Inf Dis) Quantitative SARS-CoV-2 subgenomic mRNA for Remdesivir treatment (Clin Inf Dis) Anti-spike mucosal IgA (NEJM) BNT262bs against Omicron sublineages (NEJ...
      [from content:encoded] ...subgenomic mRNA detection (J Inf Dis) Quantitative SARS-CoV-2 subgenomic mRNA for Remdesivir treatment (Clin Inf Dis) Anti-spike mucosal IgA (NEJM) BNT262bs against Omicron sublineages (NEJ...
       
      Clinical update with Dr. Daniel Griffin
      September 17, 2022 (duration 52m)
      [from description] ...) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) SARS-CoV-2 spike is associated with post...
      [from content:encoded] ...) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) SARS-CoV-2 spike is associated with post...
       
      Clinical update with Dr. Daniel Griffin
      September 10, 2022 (duration 52m)
      [from description] ...ournals) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Administration of anti–SARS-COV-2 ...
      [from content:encoded] ...ournals) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Administration of anti–SARS-COV-2 ...
       
      Clinical update with Dr. Daniel Griffin
      September 3, 2022 (duration 49m)
      [from description] ...ID) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) COVID-19–associated hospitalizations a...
      [from content:encoded] ...ID) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) COVID-19–associated hospitalizations a...
       
      Clinical update with Dr. Daniel Griffin
      August 27, 2022 (duration 48m)
      [from description] ...nfection (JAMA) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Monitoring of Pfizer-BioNTe...
      [from content:encoded] ...nfection (JAMA) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Monitoring of Pfizer-BioNTe...
       
      Clinical update with Dr. Daniel Griffin
      August 20, 2022 (duration 41m)
      [from description] ...rs (ASM) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Pfizer reports additional data on ...
      [from content:encoded] ...rs (ASM) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Pfizer reports additional data on ...
       
      Clinical update with Dr. Daniel Griffin
      August 13, 2022 (duration 40m)
      [from description] ...inistration (NIH) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Infection in vaccinated i...
      [from content:encoded] ...inistration (NIH) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Infection in vaccinated i...
       
      TWiV clinical update with Dr. Daniel Griffin
      August 6, 2022 (duration 46m)
      [from description] ...vimab is well-tolerated, viral and symptom rebound in untreated infection, extended Remdesivir infusion for persistent infection, Baricitinib in patients admitted with infection, and cogniti...
      [from content:encoded] ...vimab is well-tolerated, viral and symptom rebound in untreated infection, extended Remdesivir infusion for persistent infection, Baricitinib in patients admitted with infection, and cogniti...
       
      TWiV clinical update with Dr. Daniel Griffin
      July 30, 2022 (duration 42m)
      [from description] ...sion rates (CID) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Safety and efficacy of Mol...
      [from content:encoded] ...sion rates (CID) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Safety and efficacy of Mol...
       
      COVID-19 clinical update #124 with Dr. Daniel Griffin
      July 23, 2022 (duration 35m)
      [from description] ...ment (medRxiv) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Contribute to FIMRC fundrais...
      [from content:encoded] ...ment (medRxiv) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Contribute to FIMRC fundrais...
       
      COVID-19 clinical update #123 with Dr. Daniel Griffin
      July 16, 2022 (duration 40m)
      [from description] ...ts (Academic Pediatrics)  PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Saliva evaluatio...
      [from content:encoded] ...ts (Academic Pediatrics)  PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) Saliva evaluatio...
       
      COVID-19 clinical update #121 with Dr. Daniel Griffin
      July 2, 2022 (duration 37m)
      [from description] ...ate treatment (The Lancet) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) PAXLOVID drug in...
      [from content:encoded] ...ate treatment (The Lancet) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) PAXLOVID drug in...
       
      COVID-19 clinical update #120 with Dr. Daniel Griffin
      June 25, 2022 (duration 45m)
      [from description] ...irals in hamsters (Nature) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) PAXLOVID drug i...
      [from content:encoded] ...irals in hamsters (Nature) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) PAXLOVID drug i...
       
      COVID-19 clinical update #119 with Dr. Daniel Griffin
      June 18, 2022 (duration 46m)
      [from description] ...residual viral antigen in patients following infection, usage of Casirvimab/Imdevimab and Remdesivir in infected patients with depleted B-cells, and rheumatic symptoms following infection. S...
      [from content:encoded] ...residual viral antigen in patients following infection, usage of Casirvimab/Imdevimab and Remdesivir in infected patients with depleted B-cells, and rheumatic symptoms following infection. S...
       
      COVID-19 clinical update #118 with Dr. Daniel Griffin
      June 11, 2022 (duration 46m)
      [from description] ...al Medicine) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) PAXLOVID outcomes during infec...
      [from content:encoded] ...al Medicine) PAXLOVID patient eligibility screening checklist (FDA) Remdesivir fact sheet for providers (Veklury)  Bebtelovimab fact sheet for providers (FDA) PAXLOVID outcomes during infec...
       
      COVID-19 clinical update #117 with Dr. Daniel Griffin
      June 4, 2022 (duration 44m)
      [from description] ...fection prevention, antibody prophylaxis and vaccination in kidney transplant recipients, remdesivir and bebtelovimab fact sheets for providers, the updated guidelines on treatment with Famo...
      [from content:encoded] ...fection prevention, antibody prophylaxis and vaccination in kidney transplant recipients, remdesivir and bebtelovimab fact sheets for providers, the updated guidelines on treatment with Famo...
       
      COVID-19 clinical update #116 with Dr. Daniel Griffin
      May 28, 2022 (duration 47m)
      [from description] ...fection rebound after PAXLOVID, relapse of symptomatic infection after PAXLOVID, remdesivir and bebtelovimab fact sheets for providers, guidelines on usage of anticoagulation drugs, long cov...
      [from content:encoded] ...fection rebound after PAXLOVID, relapse of symptomatic infection after PAXLOVID, remdesivir and bebtelovimab fact sheets for providers, guidelines on usage of anticoagulation drugs, long cov...
       
      COVID-19 clinical update #115 with Dr. Daniel Griffin
      May 21, 2022 (duration 1h0m)
      [from description] In COVID-19 clinical update #115, Dr. Griffin reviews cross-variant immunity without vaccination, EU...
      [from content:encoded] In COVID-19 clinical update #115, Dr. Griffin reviews cross-variant immunity without vaccination, EU...
       
      COVID-19 clinical update #113 with Dr. Daniel Griffin
      May 7, 2022 (duration 47m)
      [from description] ... of Paxlovid, infection relapse following Paxlovid, pre-hospital administration of Remdesivir, and hospitalization with different variants. Subscribe (free): Apple Podcasts, Google Podcasts,...
      [from content:encoded] ... of Paxlovid, infection relapse following Paxlovid, pre-hospital administration of Remdesivir, and hospitalization with different variants. Subscribe (free): Apple Podcasts, Google Podcasts,...
       
      Molnupiravir with Richard Plemper
      April 14, 2022 (duration 1h29m)
      [from description] ... episode Richard on TWiV 636 Molnupiravir in ferrets (Nat Micro) Oral prodrug of Remdesivir in ferrets (Nat Commun) Letters read on TWiV 888 Timestamps by Jolene. Thanks! Weekly Picks Bria...
      [from content:encoded] ... episode Richard on TWiV 636 Molnupiravir in ferrets (Nat Micro) Oral prodrug of Remdesivir in ferrets (Nat Commun) Letters read on TWiV 888 Timestamps by Jolene. Thanks! Weekly Picks Bria...
      [from itunes:keywords] viral,pandemic,virus,viruses,virology,coronavirus,covid19,sarscov2,remdesivir,antiviraldrug,molnupiravir
       
      50 ways to zap your virus
      March 27, 2022 (duration 1h52m)
      [from description] ...t provides broad protection against a variety of hantaviruses, and development of an oral remdesivir-like antiviral that ameliorates viral disease in mice. Hosts: Vincent Racaniello, Dickson...
      [from content:encoded] ...t provides broad protection against a variety of hantaviruses, and development of an oral remdesivir-like antiviral that ameliorates viral disease in mice. Hosts: Vincent Racaniello, Dickson...
      [from itunes:keywords] viral,virus,viruses,virology,hantavirus,covid19,sarscov2,remdesivir,monoclonalantibody
       
      COVID-19 clinical update #107 with Dr. Daniel Griffin
      March 26, 2022 (duration 47m)
      [from description] ...ncy, predictive value of symptoms for diagnosis, Evusheld activity against BA.1 and BA.2, Remdesivir resistance, Ivermectin with and without strongyloidiasis, inhaled ciclesonide, home telem...
      [from content:encoded] ...ncy, predictive value of symptoms for diagnosis, Evusheld activity against BA.1 and BA.2, Remdesivir resistance, Ivermectin with and without strongyloidiasis, inhaled ciclesonide, home telem...
       
      Indolent, resistant, and losing our TMPRSS
      March 24, 2022 (duration 1h39m)
      [from description] TWiV reviews the emergence of remdesivir-resistant SARS-CoV-2 during treatment of a persistently infected immunocompromised patien...
      [from content:encoded] TWiV reviews the emergence of remdesivir-resistant SARS-CoV-2 during treatment of a persistently infected immunocompromised patien...
      [from itunes:keywords] viral,pandemic,virus,viruses,virology,coronavirus,tmprss2,omicron,covid19,sarscov2,remdesivir
       
      COVID-19 clinical update #98 with Dr. Daniel Griffin
      January 22, 2022 (duration 51m)
      [from description] ...booster effectiveness against disease, infection and vaccination in pregnant women, early Remdesivir to prevent progression to severe disease, management of hospitalized adults, Tocilizumab ...
      [from content:encoded] ...booster effectiveness against disease, infection and vaccination in pregnant women, early Remdesivir to prevent progression to severe disease, management of hospitalized adults, Tocilizumab ...
      [from itunes:subtitle] ...booster effectiveness against disease, infection and vaccination in pregnant women, early Remdesivir to prevent progression...
       
      A culture of resistance
      November 18, 2021 (duration 2h8m)
      [from description] ... would not impact immunity after infection or vaccination, and describes the isolation of remdesivir resistant mutants in cells in culture, and the emergence of amino acid changes in the spi...
      [from content:encoded] ... would not impact immunity after infection or vaccination, and describes the isolation of remdesivir resistant mutants in cells in culture, and the emergence of amino acid changes in the spi...
      [from itunes:keywords] viral,virus,viruses,virology,covid19,sarscov2,variantsofconcern,vdjrecombination,remdesivirresistance
       
      COVID-19 clinical update #85 with Dr. Daniel Griffin
      October 23, 2021 (duration 41m)
      [from description] ...e approved, giving monoclonals at home, no benefit from colchicine, and IFN does not help remdesivir. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, ...
      [from content:encoded] ...e approved, giving monoclonals at home, no benefit from colchicine, and IFN does not help remdesivir. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, ...
       
      How to stall a copy machine
      October 21, 2021 (duration 1h40m)
      [from description] TWiV explains how remdesivir inhibits the SARS-CoV-2 RNA polymerase: the drug is incorporated into the growing RNA cha...
      [from content:encoded] TWiV explains how remdesivir inhibits the SARS-CoV-2 RNA polymerase: the drug is incorporated into the growing RNA cha...
      [from itunes:keywords] viral,pandemic,virus,viruses,virology,covid19,remdesivir
       
      Clinical update #81 with Dr. Daniel Griffin
      September 25, 2021 (duration 51m)
      [from description] ...nancy, mRNA vaccine comparison, J&J vaccine booster, EUA expansion for Lilly monoclonals, remdesivir reduces risk of hospitalization, and anticoagulation regimens. Hosts: Daniel Griffin and ...
      [from content:encoded] ...nancy, mRNA vaccine comparison, J&J vaccine booster, EUA expansion for Lilly monoclonals, remdesivir reduces risk of hospitalization, and anticoagulation regimens. Hosts: Daniel Griffin and ...
      [from itunes:subtitle] ...nancy, mRNA vaccine comparison, J&J vaccine booster, EUA expansion for Lilly monoclonals, remdesivir reduces risk of hospitalization, and...
       
      COVID-19 clinical update #74 with Dr. Daniel Griffin
      August 7, 2021 (duration 49m)
      [from description] ...by antibodies produced by infection or vaccination, longer hospital stays associated with remdesivir treatment, and post-acute sequelae of infection and impact on quality of life 1-6 months ...
      [from content:encoded] ...by antibodies produced by infection or vaccination, longer hospital stays associated with remdesivir treatment, and post-acute sequelae of infection and impact on quality of life 1-6 months ...
       
      COVID-19 clinical update #68 with Dr. Daniel Griffin
      June 26, 2021 (duration 38m)
      [from description] ... patients (Op For Inf Dis) mAb treatment of ambulatory patients (Op For Inf Dis) Remdesivir reduction of mortality (Gilead) Letters read on TWiV 772 Timestamps by Jolene. Thanks! Intro mus...
      [from content:encoded] ... patients (Op For Inf Dis) mAb treatment of ambulatory patients (Op For Inf Dis) Remdesivir reduction of mortality (Gilead) Letters read on TWiV 772 Timestamps by Jolene. Thanks! Intro mus...
       
      COVID-19 clinical update #51 with Dr. Daniel Griffin
      February 27, 2021 (duration 36m)
      [from description] ... on vaccines, use of nonsteroidal anti-inflammatory drugs, little effect of vitamin D and remdesivir in clinical studies, and a long COVID research initiative from NIH. Hosts: Daniel Griffin...
      [from content:encoded] ... on vaccines, use of nonsteroidal anti-inflammatory drugs, little effect of vitamin D and remdesivir in clinical studies, and a long COVID research initiative from NIH. Hosts: Daniel Griffin...
      [from itunes:subtitle] ... on vaccines, use of nonsteroidal anti-inflammatory drugs, little effect of vitamin D and remdesivir in clinical studies, and a...
       
      COVID-19 clinical update #44 with Dr. Daniel Griffin
      January 9, 2021 (duration 32m)
      [from description] ...s of vaccination in the US, discusses a study on convalescent sera from Argentina, use of remdesivir in patients with kidney disease, and provides further considerations on the use of Ct val...
      [from content:encoded] ...s of vaccination in the US, discusses a study on convalescent sera from Argentina, use of remdesivir in patients with kidney disease, and provides further considerations on the use of Ct val...
      [from itunes:subtitle] ...s of vaccination in the US, discusses a study on convalescent sera from Argentina, use of remdesivir in patients with kidney disease, and provides further considerations on the...
       
      COVID-19 clinical update #38 with Dr. Daniel Griffin
      November 28, 2020 (duration 34m)
      [from description] ...l report on COVID-19, including new post-exposure guidelines from CDC, clinical trials of Remdesivir and convalescent plasma, FDA EUA for baricitinib and Regeneron’s monoclonal antibody and ...
      [from content:encoded] ...l report on COVID-19, including new post-exposure guidelines from CDC, clinical trials of Remdesivir and convalescent plasma, FDA EUA for baricitinib and Regeneron’s monoclonal antibody and ...
      [from itunes:keywords] viral,pandemic,virus,viruses,virology,covid19,sarscov2,remdesivir,clinicalreport,baricitinib,monoclonalantibody,danielgriffin
       
      Wake up and smell the pandemic
      October 18, 2020 (duration 2h40m)
      [from description] ...ategy calculator (and medRxiv preprint) US COVID-19 mortality rates (JAMA) Final remdesivir report (NEJM) Hydroxychloroquine for COVID-19 (NEJM) Tech position with Dr. Rosenfeld Biological s...
      [from content:encoded] ...ategy calculator (and medRxiv preprint) US COVID-19 mortality rates (JAMA) Final remdesivir report (NEJM) Hydroxychloroquine for COVID-19 (NEJM) Tech position with Dr. Rosenfeld Biological s...
       
      Nonhuman primate model for COVID-19 with Emmie de Wit
      June 2, 2020 (duration 1h7m)
      [from description] ...on the pathogenesis of infection with SARS-CoV-2 in rhesus macaques, including studies on remdesivir and vaccine candidate. Hosts: Vincent Racaniello, Rich Condit, and Brianne Barker Guest:...
      [from content:encoded] ...on the pathogenesis of infection with SARS-CoV-2 in rhesus macaques, including studies on remdesivir and vaccine candidate. Hosts: Vincent Racaniello, Rich Condit, and Brianne Barker Guest:...
      [from itunes:keywords] viral,virus,viruses,virology,covid19,sarscov2,remdesivir,nonhumanprimate,rhesusmacaque,chadoxvaccinecandidate
       
      An era of COVID-19 poppycock
      May 31, 2020 (duration 2h14m)
      [from description] ...linical update on COVID-19, then we review an Ad5 vectored SARS-CoV-2 vaccine, reports on remdesivir and hydroxychloroquine, a drug repurposing study, why some patients infect many others, r...
      [from content:encoded] ...linical update on COVID-19, then we review an Ad5 vectored SARS-CoV-2 vaccine, reports on remdesivir and hydroxychloroquine, a drug repurposing study, why some patients infect many others, r...
      [from itunes:subtitle] ...linical update on COVID-19, then we review an Ad5 vectored SARS-CoV-2 vaccine, reports on remdesivir and hydroxychloroquine, a drug repurposing study, why some patients infect many others, r...
       
      Jenner, vaccines, and COVID-19
      May 14, 2020 (duration 1h45m)
      [from description] ... and Rich explain the Jenner Institute's SARS-CoV-2 vaccine, the NIH decision to stop the Remdesivir study, and answer listener questions. Hosts: Vincent Racaniello, Rich Condit, and Kathy ...
      [from content:encoded] ... and Rich explain the Jenner Institute's SARS-CoV-2 vaccine, the NIH decision to stop the Remdesivir study, and answer listener questions. Hosts: Vincent Racaniello, Rich Condit, and Kathy ...
      [from itunes:keywords] viral,vaccine,pandemic,virus,viruses,virology,coronavirus,covid19,sarscov2,remdesivir,chadox,jennerinstitute
       
      Daniel Griffin's COVID-19 clinical report
      May 1, 2020 (duration 57m)
      [from description] ...nks for this episode Pulmonary embolism in COVID-19 (Emerg Inf Dis) Patch Study Remdesivir in adults with severe COVID-19 (Lancet) ACTT remdesivir trial (NIAID) Commentary on remdesivir ...
      [from content:encoded] ...nks for this episode Pulmonary embolism in COVID-19 (Emerg Inf Dis) Patch Study Remdesivir in adults with severe COVID-19 (Lancet) ACTT remdesivir trial (NIAID) Commentary on remdesivir ...
      [from itunes:keywords] viral,pandemic,virus,viruses,virology,coronavirus,embolism,bloodclot,covid19,sarscov2,remdesivir,clinicalreport
      •  
       
    • Weltspiegel Weltspiegel
       
      Die Sendung vom 03. Mai 2020
      October 25, 2023
      [from description] Niederlande: Helden des Alltags | USA: Corona und Gewalt | USA: Wunder-Mittel Remdesivir? | Island: Mit Massentests aus der Corona-Krise | Portugal: Mit Glück durch die Corona-Kr...
       
      USA: Wundermittel Remdesivir?
      May 4, 2020
      [from title] USA: Wundermittel Remdesivir?
      [from description] Remdesivir ist kein Wirkstoff gegen das Coronavirus, aber der Krankheitsverlauf kann möglicherweise ...
      •  
       
    • THE EMBC NETWORK THE EMBC NETWORK
       
      SCOTT SCHARA RESCUES A PATIENT FROM A HOSPITAL'S DEATH SQUAD
      April 14, 2023 (duration 35m)
      [from description] ...ceived bonuses for following NIH guidelines, including the use of Remdesivir and ventilators. Furthermore, they received direct immunity from liability under the PREP Act, which is still in...
      •  
       
    • THE EMBC NETWORK Featuring: ihealthradio and Worldwide Podcasts THE EMBC NETWORK Featuring: ihealthradio and Worldwide Podcasts
       
      SCOTT SCHARA RESCUES A PATIENT FROM A HOSPITAL'S DEATH SQUAD
      April 14, 2023 (duration 35m)
      [from description] ...bonuses for following NIH guidelines, including the use of Remdesivir and ventilators. Furthermore, they received direct immunity from liability under the PREP Act, which is still in place t...
      •  
       
    • Awakening Awakening
       
      #201 Public Health Emergency that is Killing People - Scott Schara
      January 22, 2023 (duration 40m)
      [from description] ... - Censorship - How Scotts daughter Grace was killed in the hospital - Remdesivir is killing patients - How Scott saved a disabled man from the hospital - Public Health Emergency that w...
      [from itunes:summary] ... - Censorship - How Scotts daughter Grace was killed in the hospital - Remdesivir is killing patients - How Scott saved a disabled man from the hospital - Public Health Emergency that w...
      •  
       
    • PharmaTalkRadio PharmaTalkRadio
       
      The Role of RWD in the Development of Remdesivir
      December 30, 2022 (duration 41m)
      [from title] The Role of RWD in the Development of Remdesivir
      [from description] ... they designed, developed and obtained Emergency Use Authorization and Full Approval for Remdesivir for the treatment of COVID-19 in record time. Key topics: How they built new capabilit...
      •  
       
    • New Books in Law New Books in Law
       
      The Tamiflu Trials: Profit and Public Health
      September 2, 2022 (duration 1h3m)
      [from description] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
      [from itunes:summary] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
      [from content:encoded] Before Remdesivir and Hydroxycloroquin there was Tamiflu.To prepare for Swine Flu and Bird Flu, governments...
      •  
       
    • New Books Network New Books Network
       
      The Tamiflu Trials: Profit and Public Health
      September 2, 2022 (duration 1h3m)
      [from description] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
      [from itunes:summary] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
      [from content:encoded] Before Remdesivir and Hydroxycloroquin there was Tamiflu.To prepare for Swine Flu and Bird Flu, governments...
      •  
       
    • New Books in Public Policy New Books in Public Policy
       
      The Tamiflu Trials: Profit and Public Health
      September 2, 2022 (duration 1h3m)
      [from description] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
      [from itunes:summary] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
      [from content:encoded] Before Remdesivir and Hydroxycloroquin there was Tamiflu.To prepare for Swine Flu and Bird Flu, governments...
      •  
       
    • New Books in Science, Technology, and Society New Books in Science, Technology, and Society
       
      The Tamiflu Trials: Profit and Public Health
      September 2, 2022 (duration 1h3m)
      [from description] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
      [from itunes:summary] Before Remdesivir and Hydroxycloroquin there was Tamiflu. To prepare for Swine Flu and Bird Flu, government...
      [from content:encoded] Before Remdesivir and Hydroxycloroquin there was Tamiflu.To prepare for Swine Flu and Bird Flu, governments...
    Didn't find, what you are looking for? A podcast, an episode is missing? You can provide a feed-URL, that will be added to the database. You can do that here. In case you think, there's a bug, please contact us. Thanks!